Charles River Laboratories Operating Income 2010-2025 | CRL

Charles River Laboratories annual/quarterly operating income history and growth rate from 2010 to 2025. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
  • Charles River Laboratories operating income for the quarter ending March 31, 2025 was $0.075B, a 40.73% decline year-over-year.
  • Charles River Laboratories operating income for the twelve months ending March 31, 2025 was $0.176B, a 69.4% decline year-over-year.
  • Charles River Laboratories annual operating income for 2024 was $0.227B, a 63.17% decline from 2023.
  • Charles River Laboratories annual operating income for 2023 was $0.617B, a 5.18% decline from 2022.
  • Charles River Laboratories annual operating income for 2022 was $0.651B, a 10.36% increase from 2021.
Charles River Laboratories Annual Operating Income
(Millions of US $)
2024 $227
2023 $617
2022 $651
2021 $590
2020 $433
2019 $351
2018 $331
2017 $288
2016 $238
2015 $206
2014 $178
2013 $151
2012 $166
2011 $174
2010 $-299
2009 $170
Charles River Laboratories Quarterly Operating Income
(Millions of US $)
2025-03-31 $75
2024-12-31 $-168
2024-09-30 $117
2024-06-30 $152
2024-03-31 $126
2023-12-31 $133
2023-09-30 $152
2023-06-30 $165
2023-03-31 $168
2022-12-31 $164
2022-09-30 $151
2022-06-30 $187
2022-03-31 $149
2021-12-31 $173
2021-09-30 $156
2021-06-30 $138
2021-03-31 $124
2020-12-31 $129
2020-09-30 $133
2020-06-30 $77
2020-03-31 $94
2019-12-31 $109
2019-09-30 $93
2019-06-30 $80
2019-03-31 $70
2018-12-31 $102
2018-09-30 $84
2018-06-30 $77
2018-03-31 $68
2017-12-31 $63
2017-09-30 $74
2017-06-30 $82
2017-03-31 $70
2016-12-31 $69
2016-09-30 $59
2016-06-30 $58
2016-03-31 $51
2015-12-31 $52
2015-09-30 $55
2015-06-30 $56
2015-03-31 $43
2014-12-31 $41
2014-09-30 $46
2014-06-30 $51
2014-03-31 $40
2013-12-31 $25
2013-09-30 $41
2013-06-30 $43
2013-03-31 $43
2012-12-31 $35
2012-09-30 $38
2012-06-30 $49
2012-03-31 $44
2011-12-31 $42
2011-09-30 $37
2011-06-30 $53
2011-03-31 $42
2010-12-31 $-365
2010-09-30 $6
2010-06-30 $30
2010-03-31 $30
2009-12-31 $35
2009-09-30 $44
2009-06-30 $51
2009-03-31 $40
Sector Industry Market Cap Revenue
Medical Medical Services $7.587B $4.050B
Charles River Laboratories International, Inc. is a full service, early-stage contract research organization. The company provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions globally accelerate their research and drug development efforts. The company has a diverse portfolio of discovery and safety assessment services, both Good Laboratory Practice (GLP) and non-GLP. This helps support its clients from target identification through non-clinical development. Charles River also provides a line of products and services to support clients' manufacturing activities. Utilizing the company's broad portfolio of products and services, clients can create a more flexible drug development model, aiming cost reduction, productivity enhancement and increase in speed to market. Charles River currently has three reporting segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA) and Manufacturing Support.
Stock Name Country Market Cap PE Ratio
Danaher (DHR) United States $136.013B 25.51
CVS Health (CVS) United States $78.381B 9.74
Elevance Health (ELV) United States $62.604B 8.39
Cencora (COR) United States $56.765B 19.75
DiDi Global (DIDIY) China $26.874B 28.55
Labcorp Holdings (LH) United States $20.399B 16.55
Natera (NTRA) United States $18.966B 0.00
BioMerieux (BMXMF) France $16.861B 0.00
EUROFINS SCIENT (ERFSF) Luxembourg $13.991B 0.00
CochLear (CHEOY) Australia $13.143B 0.00
Solventum (SOLV) United States $12.678B 13.42
ICON (ICLR) Ireland $11.592B 10.78
Revvity (RVTY) United States $10.993B 18.92
Viatris (VTRS) United States $10.422B 3.58
Avantor (AVTR) United States $9.056B 13.16
Medpace Holdings (MEDP) United States $8.964B 23.81
Sonic Healthcare (SKHHY) Australia $8.852B 0.00
HealthEquity (HQY) United States $8.449B 37.01
Caris Life Sciences,�Inc (CAI) United States $7.680B 0.00
Amplifon S.p.A (AMFPF) Italy $5.378B 29.44
Bausch + Lomb (BLCO) Canada $4.918B 28.96
BrightSpring Health Services (BTSG) United States $3.506B 32.17
Sotera Health (SHC) United States $3.139B 17.84
Surgery Partners (SGRY) United States $2.861B 37.20
Concentras Parent (CON) United States $2.507B 14.49
Organon (OGN) United States $2.459B 2.61
Alignment Healthcare (ALHC) United States $2.455B 0.00
GeneDx Holdings (WGS) United States $2.222B 85.57
Progyny (PGNY) United States $1.886B 41.51
PACS (PACS) United States $1.823B 0.00
Premier (PINC) United States $1.725B 13.09
GoodRx Holdings (GDRX) United States $1.672B 33.43
Ardent Health (ARDT) United States $1.589B 6.77
Teladoc Health (TDOC) United States $1.412B 0.00
QDM (QDMI) Hong Kong, SAR China $1.277B 438.00
Establishment Labs Holdings (ESTA) $1.202B 0.00
Pediatrix Medical (MD) United States $1.080B 8.22
Ryman Healthcare (RYHTY) New Zealand $0.970B 0.00
Agilon Health (AGL) United States $0.878B 0.00
AMN Healthcare Services Inc (AMN) United States $0.759B 7.10
CareDx (CDNA) United States $0.663B 10.36
Nutex Health (NUTX) United States $0.632B 9.57
So-Young (SY) China $0.595B 0.00
SBC Medicals (SBC) United States $0.585B 0.00
Embecta (EMBC) United States $0.572B 3.85
InnovAge Holding (INNV) United States $0.531B 0.00
LifeMD (LFMD) United States $0.479B 0.00
Auna S.A (AUNA) Luxembourg $0.470B 10.58
Sonida Senior Living (SNDA) United States $0.466B 0.00
Omada Health (OMDA) $0.453B 0.00
COMPASS Pathways (CMPS) United Kingdom $0.402B 0.00
Enhabit (EHAB) United States $0.342B 28.12
Oncology Institute (TOI) United States $0.312B 0.00
Performant Healthcare (PHLT) United States $0.297B 0.00
Beauty Health (SKIN) United States $0.200B 0.00
Pheton Holdings (PTHL) China $0.146B 0.00
DocGo (DCGO) United States $0.146B 23.83
Sera Prognostics (SERA) United States $0.110B 0.00
Ascend Wellness Holdings (AAWH) United States $0.079B 0.00
KindlyMD (NAKA) United States $0.066B 0.00
NeueHealth (NEUE) United States $0.061B 0.00
IceCure Medical (ICCM) Israel $0.060B 0.00
Biodesix (BDSX) United States $0.047B 0.00
Basel Medical Group (BMGL) Singapore $0.044B 0.00
ModivCare (MODV) United States $0.043B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.043B 0.00
OSR Holdings (OSRH) United States $0.020B 0.00
Intelligent Bio Solutions (INBS) United States $0.015B 0.00
Co-Diagnostics (CODX) United States $0.009B 0.00
BioNexus Gene Lab (BGLC) $0.009B 0.00
SeaStar Medical Holding (ICU) United States $0.008B 0.00
XWELL (XWEL) United States $0.006B 0.00
Aclarion (ACON) United States $0.004B 0.00
ISpecimen (ISPC) United States $0.003B 0.00
NewGenIvf Group (NIVF) Thailand $0.002B 0.00
INVO Fertility (IVF) United States $0.002B 0.00
Cano Health (CANOQ) United States $0.000B 0.00